NO20042471L - Farge-styrt molekylaer analyse for kreftprognose og diagnose - Google Patents

Farge-styrt molekylaer analyse for kreftprognose og diagnose

Info

Publication number
NO20042471L
NO20042471L NO20042471A NO20042471A NO20042471L NO 20042471 L NO20042471 L NO 20042471L NO 20042471 A NO20042471 A NO 20042471A NO 20042471 A NO20042471 A NO 20042471A NO 20042471 L NO20042471 L NO 20042471L
Authority
NO
Norway
Prior art keywords
diagnosis
color
cancer prognosis
controlled
molecules analysis
Prior art date
Application number
NO20042471A
Other languages
English (en)
Inventor
Douglas D Burkett
Original Assignee
Zila Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zila Biotechnology Inc filed Critical Zila Biotechnology Inc
Publication of NO20042471L publication Critical patent/NO20042471L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Den lokalisering hvor vevsprøver oppnås for å bestemme om celler oppviser karakteristika som er assosiert med celledifferensiering eller cancer ved molekylær analyse, bestemmes ved topisk å påføre epitelvevet et fargestoff som selektivt farger cancer- og prekankrøst vev.
NO20042471A 2001-12-14 2004-06-14 Farge-styrt molekylaer analyse for kreftprognose og diagnose NO20042471L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1700701A 2001-12-14 2001-12-14
PCT/US2002/032067 WO2003072826A1 (en) 2001-12-14 2002-10-05 Stain-directed molecular analysis for cancer prognosis and diagnosis

Publications (1)

Publication Number Publication Date
NO20042471L true NO20042471L (no) 2004-06-14

Family

ID=21780202

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20042471A NO20042471L (no) 2001-12-14 2004-06-14 Farge-styrt molekylaer analyse for kreftprognose og diagnose
NO20042472A NO20042472L (no) 2001-12-14 2004-06-14 Lys-styrt molekylaer analyse for kreftprognose og diagnose

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20042472A NO20042472L (no) 2001-12-14 2004-06-14 Lys-styrt molekylaer analyse for kreftprognose og diagnose

Country Status (10)

Country Link
US (1) US20050014145A1 (no)
EP (2) EP1463838A4 (no)
JP (2) JP2005514040A (no)
CN (1) CN1558956A (no)
AU (2) AU2002347835A1 (no)
CA (2) CA2457907A1 (no)
IL (2) IL159974A0 (no)
MX (2) MXPA04002659A (no)
NO (2) NO20042471L (no)
WO (2) WO2003057918A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU785490B2 (en) * 2000-07-20 2007-11-15 Zila Biotechnology, Inc. Improved diagnostic method for detecting dysplastic epithelial tissue
AU776256B2 (en) 2000-09-26 2004-09-02 Zila Biotechnology, Inc. Method for early prediction of the onset of invasive cancer
AU2004323582A1 (en) * 2004-09-28 2006-04-06 Zila Pharmaceuticals, Inc. Methods for detecting abnormal epithelial tissue
US20090023138A1 (en) * 2007-07-17 2009-01-22 Zila Biotechnology, Inc. Oral cancer markers and their detection

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321251A (en) * 1979-12-19 1982-03-23 The United States Of America As Represented By The Department Of Health And Human Services Detection of malignant lesions of the oral cavity utilizing toluidine blue rinse
US5179938A (en) * 1983-02-17 1993-01-19 The Trylon Corporation Apparatus for endoscopic examination of body cavity using chemiluminescent light source
DK0565668T3 (da) * 1991-10-31 2000-01-31 Zila Inc Biologisk farvemiddelsammensætning, fremgangsmåde til fremstilling deraf og til anvendelse til aftegning af epitelcancer
WO1994019492A1 (en) * 1993-02-24 1994-09-01 Mayo Foundation For Medical Education And Research Tumor-specific genomic instability as a prognostic indicator
US6235470B1 (en) * 1993-11-12 2001-05-22 The Johns Hopkins University School Of Medicine Detection of neoplasia by analysis of saliva
US6025127A (en) * 1994-01-14 2000-02-15 The Johns Hopkins University School Of Medicine Nucleic acid mutation detection in histologic tissue
US5786227A (en) * 1995-06-07 1998-07-28 Biex, Inc. Fluid collection kit and method
KR19990067532A (ko) * 1995-11-13 1999-08-25 코텍스(유케이) 리미티드 진단 시험 장치
KR100342342B1 (ko) * 1996-01-16 2002-08-22 자일러, 인코포레이티드 구강암및전암성질환의체내검출을위한방법및조성물
US6291163B1 (en) * 1996-08-28 2001-09-18 The Johns Hopkins University School Of Medicine Method for detecting cell proliferative disorders
US6086852A (en) * 1997-11-13 2000-07-11 Zila, Inc. In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue
US6405070B1 (en) * 1998-06-16 2002-06-11 Bhaskar Banerjee Detection of cancer using cellular autofluorescence
US6256530B1 (en) * 1998-09-15 2001-07-03 Denvu, L.L.C. Optical instrument and technique for cancer diagnosis using in-vivo fluorescence emission of test tissue
AU2000237154A1 (en) * 2000-02-28 2001-09-12 Zila, Inc. Method for detecting and killing epithelial cancer cells
AU776256B2 (en) * 2000-09-26 2004-09-02 Zila Biotechnology, Inc. Method for early prediction of the onset of invasive cancer

Also Published As

Publication number Publication date
JP2005518221A (ja) 2005-06-23
MXPA04002659A (es) 2004-06-18
IL159974A0 (en) 2004-06-20
IL159975A0 (en) 2004-06-20
AU2002367731B2 (en) 2008-11-13
NO20042472L (no) 2004-06-14
CA2457407A1 (en) 2003-07-17
MXPA04002658A (es) 2004-06-18
JP2005514040A (ja) 2005-05-19
EP1463838A4 (en) 2006-06-07
EP1463833A1 (en) 2004-10-06
CA2457907A1 (en) 2003-09-04
US20050014145A1 (en) 2005-01-20
WO2003072826A1 (en) 2003-09-04
AU2002347835A1 (en) 2003-07-24
AU2002367731A1 (en) 2003-09-09
EP1463838A1 (en) 2004-10-06
CN1558956A (zh) 2004-12-29
WO2003057918A1 (en) 2003-07-17
EP1463833A4 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
ATE490466T1 (de) Als interne funktionskontrolle in tests zum nachweis von seltenen zellen verwendete markierte zellen
ATE490465T1 (de) Diagnose- und prognoseverfahren von blasenkrebs.
WO2004019864A3 (en) Quantitative rt-pcr to ac133 to diagnose cancer and monitor angiogenic activity in a cell sample
BR0212125A (pt) Métodos para diagnosticar doença, diagnosticar malignidade, triar malignidade e monitorar malignidade, em um indivìduo sob teste, e, kit para examinar um espécime biológico quanto à presença de células malignas, fragmentos celulares derivados de células malignas ou detritos celulares derivados de células malignas
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
ATE238556T1 (de) Krebsbehandlung
BRPI0417903A (pt) método de melhorar a detecção de sinal de um componente de parede celular de células
PT1325343E (pt) Aumento do rendimento num analisador clinico automatico atraves da divisao de ensaios em funcao do tipo de ensaios
BRPI0509978A (pt) uso de padrão proteÈmico de plasma para diagnóstico, classificação, previsão de resposta à terapia e comportamento clìnico, estratificação de terapia, e monitoramento de doença em malignidades hematológicas
CA2486456A1 (en) Method for sequence determination using nmr
EP1399739A4 (en) METHOD AND KITS FOR DIAGNOSIS OF TUMOR ENGENITATION AND DETERMINATION OF RESISTANCE TO THE ANTINEOPLASTIC EFFECTS OF ANTI-STROGEN THERAPY
NO20042471L (no) Farge-styrt molekylaer analyse for kreftprognose og diagnose
AU2003260457A1 (en) A method and kit for the quantitative and/or qualitative detection of components in a sample
WO2006135775A3 (en) Rapid saccharide biomarker assay
FR2795823B1 (fr) Methodes et kits pour le diagnostic ou le suivi d'une pathologie synoviale ou osteoarticulaire comprenant l'utilisation d'un marqueur specifique de la degradation du tissu synovial
BR0105768A (pt) Aparelho e método para teste em uma linha de processo
CA2358504A1 (en) Methods of determining an increased risk of a woman carrying a downs syndrome affected fetus by measuring an analyte in a biological sample
Roesch et al. Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating nevi
BR0015706A (pt) Processo prognóstico para a previsão precoce do eventual desenvolvimento de cãncer invasivo
ATE486964T1 (de) Molekulares verfahren zur diagnose von prostatakrebs
BR0010259A (pt) Método para caracterização de células, kit, e, aparelho para executar análise de par‰metro único ou de múltiplos par‰metros em uma suspensão de células
WO2005016230A3 (en) Evaluating protein signatures
Kojima et al. Detection of elevated proteins in peritoneal dissemination of gastric cancer by analyzing mass spectra data of serum proteins
DE602004026869D1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers
DE60327776D1 (de) Sonden zum nachweis von tumorzellen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application